Rhodesiense Human African Trypanosomiasis: Treatment When Recommended First-Choice Medicines Are Not Readily Available
This protocol addresses Trypanosoma brucei rhodesiense human African trypanosomiasis (HAT) in the specific situation where the recommended first-choice medicines cannot be obtained without delay. Beginning treatment promptly — even when optimal agents are absent — is the priority.
Clinical Scenario
Rhodesiense HAT confirmed or strongly suspected; recommended first-choice medicines for this form of the disease are not readily available at the point of care. An evidence-based interim treatment strategy applies until optimal therapy can be sourced.
Approach (partial overview)
Immediate interim antiparasitic treatment with pentamidine is recommended to begin without delay — the complete dosing regimen, administration details, and the protocol for transitioning to first-choice therapy are available in the full structured protocol.
References
- In settings where first-choice medicines are not readily available, immediate interim treatment with pentamidine is recommended.
- Treatment should be switched to the first-choice medicines as soon as they become available.
View source ↗